MAX
Company Analysis Atossa Therapeutics, Inc.
1. Summary
Advantages
- The stock's return over the last year (471.01%) is higher than the sector average (22.65%).
- Current debt level 0.0013% is below 100% and has decreased over 5 years from 0.0421%.
Disadvantages
- Price (5.01 $) is higher than fair price (2.77 $)
- Dividends (0%) are below the sector average (0.51%).
- The company's current efficiency (ROE=-31.39%) is lower than the sector average (ROE=102.4%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Atossa Therapeutics, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 9.6% | -2.5% | -1.6% |
| 90 days | 667.2% | 3% | -4.5% |
| 1 year | 471% | 22.7% | 16.5% |
ATOS vs Sector: Atossa Therapeutics, Inc. has outperformed the "Healthcare" sector by 448.35% over the past year.
ATOS vs Market: Atossa Therapeutics, Inc. has outperformed the market by 454.53% over the past year.
Highly volatile price: ATOS is significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of more than +/- 15% per week.
Long period: ATOS with weekly volatility of 9.06% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Above fair price: The current price (5.01 $) is higher than the fair price (2.77 $).
Price is higher than fair: The current price (5.01 $) is 44.7% higher than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (-3.88) is lower than that of the sector as a whole (26.63).
P/E vs Market: The company's P/E (-3.88) is higher than that of the market as a whole (-88.36).
5.3. P/BV
P/BV vs Sector: The company's P/BV (1.72) is lower than that of the sector as a whole (244.09).
P/BV vs Market: The company's P/BV (1.72) is lower than that of the market as a whole (81.84).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0) is lower than that of the sector as a whole (127.74).
P/S vs Market: The company's P/S indicator (0) is lower than that of the market as a whole (116.29).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-2.02) is higher than that of the sector as a whole (-21.78).
EV/Ebitda vs Market: The company's EV/Ebitda (-2.02) is higher than that of the market as a whole (-79.49).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.29% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.29%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-28.94%).
6.4. ROE
ROE vs Sector: The company's ROE (-31.39%) is lower than that of the sector as a whole (102.4%).
ROE vs Market: The company's ROE (-31.39%) is lower than that of the market as a whole (23.33%).
6.6. ROA
ROA vs Sector: The company's ROA (-29.54%) is lower than that of the sector as a whole (-4.47%).
ROA vs Market: The company's ROA (-29.54%) is lower than that of the market as a whole (4.25%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (-15.9%) is lower than that of the sector as a whole (0.7%).
ROIC vs Market: The company's ROIC (-15.9%) is lower than that of the market as a whole (8.8%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.51%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
